BOZCAARMUTLU, A. Et Al. 2022. The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver. DRUG AND CHEMICAL TOXICOLOGY , vol.45, no.3 , 990-998.

BOZCAARMUTLU, A., Sapmaz, C., BOZDOĞAN, Ö., Kukner, A., KILINÇ, L., KAYA, S. T., ... Ozarslan, O. T.(2022). The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver. DRUG AND CHEMICAL TOXICOLOGY , vol.45, no.3, 990-998.

BOZCAARMUTLU, AZRA Et Al. "The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver," DRUG AND CHEMICAL TOXICOLOGY , vol.45, no.3, 990-998, 2022

BOZCAARMUTLU, AZRA Et Al. "The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver." DRUG AND CHEMICAL TOXICOLOGY , vol.45, no.3, pp.990-998, 2022

BOZCAARMUTLU, A. Et Al. (2022) . "The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver." DRUG AND CHEMICAL TOXICOLOGY , vol.45, no.3, pp.990-998.

@article{article, author={AZRA BOZCAARMUTLU Et Al. }, title={The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver}, journal={DRUG AND CHEMICAL TOXICOLOGY}, year=2022, pages={990-998} }